Nu-Med Plus, Inc.
NUMD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,282 | $3,306 | $1,319 | $2,568 |
| - Cash | $2 | $7 | $73 | $12 |
| + Debt | $100 | $100 | $100 | $8 |
| Enterprise Value | $1,380 | $3,399 | $1,346 | $2,565 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$13 | -$13 | -$23 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$118 | -$172 | -$818 |
| % Margin | – | – | – | – |
| Net Income | -$68 | -$126 | -$130 | -$830 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.001 | -0.002 | -0.002 | -0.011 |
| % Growth | 46.7% | 6.3% | 85.8% | – |
| Operating Cash Flow | -$4 | -$66 | -$38 | -$207 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$4 | -$66 | -$38 | -$207 |